Additionally, the expression of p53 and p21 as well as the proportions of SA-β-gal- and SAHF-positive cells for AGTR1-knockout HCC cells was ameliorated by ERK agonist EGF in HCC cells. This evidence concerns the gene EGF and hepatocellular carcinoma.